Announced Wed, 4 Nov, 2026 · 18:34 IST

Unaudited results filed for period ended September 30, 2026

Revenue growth above 20%Results View source PDF Explain this filing

RBS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.2%Reaction day

₹77.00

prior close

₹77.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+3.7

10m

+3.9

15m

+3.9

30m

+2.6

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

+5.2pendingpending

Next day

+7.5pendingpending

———

15d

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ramdevbaba Solvent filed consolidated unaudited financial results for the period ended September 30, 2026; the supplied text does not include figures for the latest quarter or its year-earlier comparison. Standalone unaudited results for the same period were also filed.

Likely market impact

Without the financial figures, investors cannot assess earnings, margins, cash flow or the likely effect on the share price.

By the numbersConsolidated · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹613.9 Cr	₹385.6 Cr	+59.2%
Operating profit	₹21.36 Cr	₹6.16 Cr	+247.0%
Profit after tax	—	—	—
EBITDA margin	—	—	—

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.